Thanks for the answer. I don't know, but maybe the current Directors are more IT tech and market savvy and less finance /M&A savvy and thought they needed that expertise to draw on???
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025